PHARMACY Club & Aspen Pharmacare have jointly developed a new online CPD-accredited module for pharmacists titled 'GORD and PPI Therapy: a Burning Topic'.
This learning module has been designed to help pharmacists identify patients who may suffer from gastro-oesophageal reflux disease (GORD) and may benefit from an over-the-counter proton pump inhibitor (PPI), as well as those who may benefit from stepping-down their PPI therapy, as recommended by guidelines.
See pharmacyclub.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Nov 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Nov 19